1Phase III Study of Teva's Oral Laquinimod Published in the New England Journal of Medicine Demonstrates Clinical Benefits for Multiple Sclerosis Patients[EB/OL]. (2012-03-15) [2012-04-04]. http://www.drugs.com/clinical_trials/phase-iii-study- teva-s-oral-laquinimod-published-new-england-j oumal-medicine- demonstrates-clinical- 13190. html.
